granisetron has been researched along with Lymphoma, Non-Hodgkin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, H; Kojima, Y; Matsumoto, S; Miyazawa, K; Nagai, H; Nakamura, A | 1 |
| Akashi, K; Kadoyama, K; Kamezaki, K; Kato, K; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Takenaka, K; Uchida, M | 1 |
| Akashi, K; Hosohata, K; Ikesue, H; Kato, K; Makihara, Y; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Suetsugu, K; Uchida, M | 1 |
| Leelasiri, A; Mongkonsritragoon, W; Numbenjapon, T; Prayoonwiwat, W; Sriswasdi, C | 1 |
| Hiraoka, A; Kageyama, T; Kakishita, E; Masaoka, T; Matsuzawa, Y; Nagai, K; Okuda, K; Oshiba, S; Tatsumi, N; Uchino, H | 1 |
| Collini, D; Fedele, P; Lucia, C; Manicone, M; Spina, M; Tirelli, U; Valentini, M | 1 |
| Cassoni, AM; Gibbs, SJ | 1 |
| Belkacémi, Y; Gorin, NC; Laporte, JP; Laugier, A; Ozsahin, M; Pène, F; Rio, B; Sutton, L; Touboul, E | 1 |
| Fujii, H; Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakagawa, H; Nakao, M; Nakazawa, N; Ookawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
5 trial(s) available for granisetron and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cross-Over Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Metoclopramide; Middle Aged; Nausea; Patient Satisfaction; Prednisone; Probability; Treatment Outcome; Vincristine; Vomiting | 2002 |
[Granisetron oral phase III clinical trial--study on the inhibitory effect of granisetron for nausea/vomiting induced by chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Granisetron; Hodgkin Disease; Humans; Indazoles; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Vomiting | 1993 |
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1995 |
A pilot study to evaluate the cost-effectiveness of ondansetron and granisetron in fractionated total body irradiation.
Topics: Administration, Oral; Antiemetics; Bone Marrow Transplantation; Cost-Benefit Analysis; Drug Administration Schedule; Evaluation Studies as Topic; Follow-Up Studies; Granisetron; Humans; Injections, Intravenous; Leukemia; Lymphoma, Non-Hodgkin; Ondansetron; Pilot Projects; Radiotherapy Dosage; Time Factors; Transplantation Conditioning; Vomiting; Whole-Body Irradiation | 1996 |
[Clinical study on the inhibitory effect of a 5-HT3 antagonist, granisetron, for nausea and vomiting induced by chemotherapy (CHOP, VEPA, high-dose ETP) for non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Serotonin Antagonists; Vincristine; Vomiting | 1998 |
4 other study(ies) available for granisetron and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis.
Topics: Adult; Aged; Antineoplastic Agents; Aprepitant; Cost-Benefit Analysis; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Multiple Myeloma; Nausea; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Vomiting | 2017 |
Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP.
Topics: Adult; Aged; Aging; Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Prednisone; Quinuclidines; Risk Factors; Rituximab; Sex Characteristics; Treatment Outcome; Vincristine; Vomiting; Young Adult | 2017 |
Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Bendamustine Hydrochloride; Dexamethasone; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Retrospective Studies; Vomiting | 2018 |
Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Topics: Adolescent; Adult; Age Factors; Antiemetics; Body Weight; Bone Marrow Transplantation; Diuresis; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Sex Factors; Whole-Body Irradiation | 1996 |